ONTEYA

Welcome to the Brand page for “ONTEYA”, which is offered here for Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; pharmaceutical preparations for the treatment of car t-cell induced cytokine release syndrome;.

Its status is currently believed to be active. Its class is unavailable. “ONTEYA” is believed to be currently owned by “FRESENIUS KABI AG”.

Owner:
FRESENIUS KABI AG
Owner Details
Description:
Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; pharmaceutical preparations for the treatment of CAR T-cell induced cytokine release syndrome;
Categories: PHARMACEUTICAL PREPARATIONS HUMAN USE